Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
基本信息
- 批准号:10294012
- 负责人:
- 金额:$ 354.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocacyAftercareAgeCLIA certifiedCancer PatientCancer SurvivorCapitalCharacteristicsCholangiocarcinomaColorectal CancerCommunicationCommunitiesComplexDevelopmentDisadvantagedDisciplineEnsureEnvironmentEvaluation ResearchFamilyFosteringGenomicsGoalsHealth BenefitHealth systemInvestmentsKnowledgeLeadLeadershipMalignant NeoplasmsMethodologyMultiple MyelomaParticipantPatient advocacyPatientsPopulationPositioning AttributeProviderResearchResearch PersonnelResourcesRural PopulationScienceTechnologyTestingUnderserved PopulationUniversitiesVisionWashingtonanticancer researchcancer genomicscancer health disparitycareerevidence basefollow-upgenome sequencingimprovedinnovationinterdisciplinary collaborationmemberoutreachpatient engagementpatient orientedpatient populationrare cancerrecruitsuccesssynergismtumor
项目摘要
PROJECT SUMMARY
Vision. Participant engagement and sequencing research from the Washington University Participant
Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) will fill critical gaps in knowledge,
methodology, and characterization of understudied cancer populations, leading to optimal approaches to
participant engagement, outreach, and communication in genomic characterization studies.
Goal. The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches direct
engagement of cancer patients and post-treatment cancer survivors as participants in cancer research. Our
focus is on rare and understudied cancer populations with significant disparities including cholangiocarcinoma,
multiple myeloma, and colorectal cancer under age 50. Participant engagement strategies are most effective
when they are adapted and implemented in real-world settings in partnership with community and patient
advocacy stakeholders.
Setting. Our Center will be housed in an exceptional environment that fosters transdisciplinary collaboration,
catalyzes new ideas in patient engagement, and ensures support for patient engagement and genome
sequencing that finds solutions for complex recruitment and engagement challenges in real-world settings with
underrepresented patient populations. Significant matching contributions from Washington University will allow
us to quickly and strategically invest in ideas.
Aims. The specific aims of the Center are to: (1) Advance the field of participant engagement to study cancer
disparities and rare cancers by conducting innovative and impactful direct stakeholder engagement with
continuous evaluation and research; (2) Expand an exceptional, diverse team of investigators, patients, and
advocacy stakeholders; (3) Address cancer disparities by understanding barriers to and improving the ability
for disadvantaged and understudied populations to encounter, use, and benefit from genomic sequencing and
analysis; (4) Organize and integrate Center units to facilitate transdisciplinary, team science within our Center
and across the PE-CGS Network.
Innovations and impact. The WU-PE-CGS builds on a long and outstanding record of leadership in both cancer
disparities and genomic research across the cancer continuum. We will be particularly innovative and allow for
a significant return on the scientific investment in several ways. First, our Center has distinctive features that
include a combined focus on cancer disparities, the application of strategies to increase participant
engagement in research, success in biospecimen acquisition, and exceptional genomic sequencing expertise.
Second, we have assembled a diverse, world class team with strong linkages to multiple rare and understudied
cancers. Third, we engage investigators from different disciplines and invest in the development of early
career scholars. Fourth, we will strategically and creatively disseminate products in ways that will benefit
researchers, practitioners, and community members. Fifth, we will partner with exceptional patient-centered
and wide-reaching advocacy groups to engage patients, optimize recruitment, and seamlessly return results.
Input from these groups, patients, and their families is a key strength that will leverage our track record of
stakeholder-engaged research. And finally, we have developed a focused strategy for collective integration of
our units. These synergies will allow our Center to become a national resource for optimal approaches to
participant engagement, outreach, and communication in genomic characterization studies and other studies
as technologies advance that will accelerate progress for both the scientific community, patients and their
communities.
In summary, we are uniquely situated to advance a network of participant engagement and sequencing
researchers, integrate research with patients and their stakeholders, build intellectual capital, and significantly
enhance the capacity for participant engagement and genomic characterization studies. This Center will
ultimately benefit health systems, providers, and people with rare cancers and lead to a reduction in cancer
disparities.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRAHAM A. COLDITZ其他文献
GRAHAM A. COLDITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRAHAM A. COLDITZ', 18)}}的其他基金
Core C: Biostatistical and Bioinformatics Core
核心 C:生物统计和生物信息学核心
- 批准号:
10708578 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤比较模型:预防、治疗和缩小差异
- 批准号:
10491296 - 财政年份:2021
- 资助金额:
$ 354.37万 - 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤比较模型:预防、治疗和缩小差异
- 批准号:
10331128 - 财政年份:2021
- 资助金额:
$ 354.37万 - 项目类别:
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
- 批准号:
10759096 - 财政年份:2021
- 资助金额:
$ 354.37万 - 项目类别:
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
- 批准号:
10599739 - 财政年份:2021
- 资助金额:
$ 354.37万 - 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤的比较模型:预防、治疗和缩小差异
- 批准号:
10831693 - 财政年份:2021
- 资助金额:
$ 354.37万 - 项目类别:
相似海外基金
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Research Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Operating Grants
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Continuing Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 354.37万 - 项目类别:
Miscellaneous Programs